Sponsored by MGRI Division of Clinical Research and Harvard Center for Bioethics Title: Ethical Considerations of Access to Investigational Medicines Speaker: Karla G. Childers, BA, MSJ, MSBE, Head, Bioethics-based Science & Technology Policy, Office of the Chief Medical Officer, Johnson & Johnson